Navigation Links
Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
Date:12/17/2007

ROCKVILLE, Md., Dec. 17 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today favorable results from preclinical studies of its recombinant trivalent seasonal influenza virus-like particle (VLP) vaccine. The trivalent seasonal influenza vaccine is the second of two influenza vaccine programs that Novavax is developing using its recombinant VLP technology. The Company's pandemic influenza vaccine candidate is currently in Phase I/IIa clinical trials.

In a study using mice, two injections of Novavax's trivalent seasonal flu vaccine without an adjuvant induced strong HAI antibody responses against all 3 influenza subtypes contained in the vaccine including H3N2, H1N1, and B. The study showed that when all three seasonal influenza VLPs were given as a single trivalent vaccine, the immune response to each subtype was comparable to that observed when the VLPs were given in a monovalent formulation. Three different dosages of the trivalent vaccine were given; the anti-hemagglutinin (HI) antibody titer increased with dosage and protective levels of HI antibody titers were observed against each subtype at a dose of 3 g of hemagglutinin.

This preclinical study will be included in an Investigational New Drug ("IND") submission for the seasonal influenza vaccine currently targeted for the second quarter of 2008, with human trials to follow after clearance by the Food & Drug Administration ("FDA"). A toxicology study for the seasonal influenza vaccine has also been initiated as planned.

"We are pleased that the results from this seasonal influenza vaccine preclinical study are in line with our expectations. We are aggressively moving this program forward to file an IND as planned in the second quarter of 2008. If
'/>"/>

SOURCE Novavax, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... LEHIGH VALLEY, Pa. , July 28, 2014 /PRNewswire/ ... a reliable, uninterrupted supply of medical oxygen is vital ... company to technical innovations that not only improve the ... gas use. Air Products will highlight these systems—including systems ... systems that reduce oxygen loss—from August 4-5 at the ...
(Date:7/28/2014)... Research and Markets  has announced the addition of the ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... and pain in the human body,s joints such as wrists, ... of the tissues that surround the joints and in other ... slowly, usually just mild pain around the joints coupled with ...
(Date:7/28/2014)... 28, 2014  TNI BioTech, Inc. (OTCQB: TNIB) ... on the development, marketing and distribution of opioid-related ... proxy materials with the Securities and Exchange Commission ... Shareholders to be held on Thursday, September 4, ... record date for determining those shareholders eligible to ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Global Rheumatoid Arthritis Drugs Market 2014-2018 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... N.J., Dec. 13, 2010 PharmaNet Development Group, ... to pharmaceutical, biotechnology, generic drug and medical device ... launching two technology platforms – Initiator™ and PKS™ ... study timelines by accelerating data acquisition and the ...
... MedShape Solutions, Inc., the world,s leading developer of ... today announced a strategic investment and development agreement ... identifies innovative technology solutions to support the missions ... MedShape,s business is built on a technology platform ...
Cached Medicine Technology:PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics 2PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics 3MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community 2
(Date:7/28/2014)... 2014 Thousands of DePuy Pinnacle hip ... individuals who were allegedly injured by a metal-on-metal version ... forward in U.S. District Court, Northern District of Texas, ... on July 18, 2014, U.S. District Judge Ed Kinkeade ... Plaintiffs’ Steering Committee that sought the deposition of a ...
(Date:7/28/2014)... 28, 2014 Ticket Down is ... in Miami, FL at the Sun Life Stadium in ... football between Argentina and Brazil has is one that has ... more rivalries are forming on a consistent basis. The ... new height in the recent 2014 World Cup. To ...
(Date:7/28/2014)... Endurance runners are far more likely to die of ... a new study. The researchers pointed out ... are actually 10 times more likely to develop severe ... death of a young and apparently healthy person due ... often gets a lot more media attention. "This ...
(Date:7/28/2014)... Washington, NY (PRWEB) July 28, 2014 Parker ... many years fighting to ensure that the heroes of 9/11 ... Fund (VCF) has announced an important deadline. According to a ... were diagnosed with a covered cancer on or before October ... October 12, 2014. First responders and others who were allegedly ...
(Date:7/28/2014)... 2014 Bariatric Eating, a leading supplier ... it will be introducing three additional flavors to its ... The additional flavors include: , Inspire Summer Melon - ... Inspire Pomegranate Razz Berry -­ Pomegranate, razz and other ... cone , Bariatric Eating's Inspire protein powders ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2
... ... renewable resource. , ... 26, 2010 -- Laser and copier toners use over 146,000,000 gallons of oil per year. ... Forestry products, therefore, eliminating the need for petroleum products. The term bio-product is short ...
... New ... leading dermatologist Dr. David J. Goldberg. , ... (PRWEB) June 25, 2010 -- Dr. David J. Goldberg, a leading dermatologist and ... today that the practice will be offering the new eMatrix ™ treatment for acne ...
... in mice testes suggests a similar process that ... a Penn State College of Agricultural Sciences reproductive ... that signals stem cells to decide whether to ... self-renew and remain stem cells. By manipulating STAT3, ...
... Are ... Coker Offers an Answer. , ... Alpharetta, GA (Vocus) June 24, 2010 — Given the increase in patients across the ... specialties -- the role of advanced practitioners is evolving, but not to the liking of ...
... DecisionWise ... and Development. , ... (PRWEB) June 25, 2010 -- A new self-initiated 360-degree feedback survey ... System makes it possible for an individual to initiate his or her own personal ...
... renowned experts have assembled in Dubrovnik, Croatia to discuss ... in diagnostic techniques that will shape the future management ... cause of cancer-related death globally, and a leading ... "This HCC conference is a significant milestone ...
Cached Medicine News:Health News:Great Office Buys Announces the Addition of Elite Brand Bio-Based Toners to their Product Line 2Health News:Skin Laser and Surgery Specialists Offers New eMatrix™ Treatment for Acne Scarring 2Health News:Skin Laser and Surgery Specialists Offers New eMatrix™ Treatment for Acne Scarring 3Health News:Mechanism that may trigger degenerative disease identified 2Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 2Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 3Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 4Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 5Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 6Health News:Self-Service 360-Degree Feedback Gives Managers Power Over Their Own Leadership Development 2Health News:International liver cancer congress provides possible solutions to reduce significant burden 2Health News:International liver cancer congress provides possible solutions to reduce significant burden 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: